Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/CTXR
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Citius Pharmaceuticals Inc (CTXR) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

CTXR trades at $0.6063, down 4.89% today, with a bearish technical outlook from moving averages. The company shows early commercial traction with $7.1M revenue in the first nine months of fiscal 2026 from LYMPHIR sales, but fundamentals remain weak with a -651.27% net income margin and negative EBITDA of -$38.20M. Analyst sentiment is strongly positive with 83.33% buy ratings, contrasting with the challenging financial performance.
The stock presents high-risk speculation with significant cash burn offset by financing activities. Investment opportunity hinges on LYMPHIR's commercial success in the $400M+ CTCL market, while risks include sustained losses, execution challenges, and dependence on continued capital raises to fund operations amid negative cash flow from operations.
Read full analysis

Key Stats

  • Market Cap
    $16.47M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $1.82
  • 52W Low
    $0.48
  • Typical Hold Time
    -
  • Enterprise Value
    $6.64M
  • Div Yield
    -
  • Trading Activity
    -
$0.6
52W Low: $0.48
20 Jul 2026
52W High: $1.82
24 Oct 2025

Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.48 and a high of $1.82, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Most Recent News

Content is generated by Aura AI

Intel sold $20B stock at $95/share; shares now trade below $93.

Intel recently sold $20 billion worth of its stock at $95 per share. Since the sale, the stock price has dropped and is now trading below $93. This decline means investors who bought at the offering price are facing immediate losses. The price moveme...

Market News
2 hours ago
Keith Noonan
Bearish
news icon
pluang ai news

67% of SoftBank's U.S. stock portfolio is in Intel, with no new shares bought last quarter.

Masayoshi Son holds 67% of SoftBank's U.S. stock portfolio in Intel shares. Despite this large stake, SoftBank did not purchase any additional Intel shares in the last quarter. This suggests a pause or cautious approach in expanding their investment ...

Market News
2 hours ago
Daniel Sparks
Bearish
news icon
pluang ai news

Butterfly Network CEO Joseph Devivo sells 68,346 shares, signaling insider stock movement.

Joseph Devivo, CEO of Butterfly Network, sold 68,346 shares of the company. Insider sales like this can indicate personal financial decisions or strategic moves regarding the company's stock. Investors often watch such transactions closely as they ma...

Market News
3 hours ago
Brendan Coffey
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $16.47M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $1.82
  • 52W Low
    $0.48
  • Typical Hold Time
    -
  • Enterprise Value
    $6.64M
  • Div Yield
    -
  • Trading Activity
    -
$0.6
52W Low: $0.48
20 Jul 2026
52W High: $1.82
24 Oct 2025

Track Citius Pharmaceuticals Inc (CTXR) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.48 and a high of $1.82, highlighting its annual price range. Buy and sell Citius Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!